Fiduciary Group LLC grew its holdings in Colgate-Palmolive (NYSE:CL) by 4.7% in the 1st quarter, HoldingsChannel reports. The firm owned 8,403 shares of the company’s stock after buying an additional 378 shares during the quarter. Fiduciary Group LLC’s holdings in Colgate-Palmolive were worth $576,000 as of its most recent SEC filing.
Other large investors have also bought and sold shares of the company. Vanguard Group Inc raised its stake in shares of Colgate-Palmolive by 1.0% during the 3rd quarter. Vanguard Group Inc now owns 73,520,894 shares of the company’s stock worth $4,922,224,000 after acquiring an additional 734,860 shares in the last quarter. BlackRock Inc. raised its stake in shares of Colgate-Palmolive by 13.5% during the 4th quarter. BlackRock Inc. now owns 60,648,605 shares of the company’s stock worth $3,609,804,000 after acquiring an additional 7,236,342 shares in the last quarter. Massachusetts Financial Services Co. MA raised its stake in shares of Colgate-Palmolive by 3.2% during the 4th quarter. Massachusetts Financial Services Co. MA now owns 32,521,377 shares of the company’s stock worth $1,935,674,000 after acquiring an additional 1,000,161 shares in the last quarter. Northern Trust Corp raised its stake in shares of Colgate-Palmolive by 3.0% during the 4th quarter. Northern Trust Corp now owns 10,760,664 shares of the company’s stock worth $640,475,000 after acquiring an additional 309,387 shares in the last quarter. Finally, Geode Capital Management LLC raised its stake in shares of Colgate-Palmolive by 7.9% during the 4th quarter. Geode Capital Management LLC now owns 10,540,277 shares of the company’s stock worth $626,200,000 after acquiring an additional 768,550 shares in the last quarter. Institutional investors and hedge funds own 74.63% of the company’s stock.
Several research analysts recently commented on the stock. UBS Group boosted their price objective on shares of Colgate-Palmolive from $71.00 to $75.00 and gave the stock a “buy” rating in a research note on Friday, March 29th. Zacks Investment Research downgraded shares of Colgate-Palmolive from a “hold” rating to a “sell” rating in a research report on Tuesday, April 23rd. Jefferies Financial Group boosted their target price on shares of Colgate-Palmolive from $61.00 to $73.00 and gave the stock an “in-line” rating in a research report on Monday, April 29th. They noted that the move was a valuation call. JPMorgan Chase & Co. raised shares of Colgate-Palmolive from an “underweight” rating to a “neutral” rating and boosted their target price for the stock from $62.00 to $70.00 in a research report on Monday, April 29th. Finally, ValuEngine raised shares of Colgate-Palmolive from a “hold” rating to a “buy” rating in a research report on Monday, May 13th. One analyst has rated the stock with a sell rating, twelve have given a hold rating and five have assigned a buy rating to the stock. The company presently has a consensus rating of “Hold” and an average price target of $69.53.
Colgate-Palmolive (NYSE:CL) last released its quarterly earnings data on Friday, April 26th. The company reported $0.67 EPS for the quarter, beating the consensus estimate of $0.66 by $0.01. The business had revenue of $3.88 billion for the quarter, compared to the consensus estimate of $3.86 billion. Colgate-Palmolive had a net margin of 15.08% and a negative return on equity of 3,730.37%. The business’s revenue for the quarter was down 2.9% on a year-over-year basis. During the same period in the prior year, the firm earned $0.74 EPS. On average, research analysts expect that Colgate-Palmolive will post 2.83 EPS for the current fiscal year.
The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, May 15th. Stockholders of record on Friday, April 19th were issued a $0.43 dividend. This is an increase from Colgate-Palmolive’s previous quarterly dividend of $0.42. This represents a $1.72 annualized dividend and a dividend yield of 2.42%. The ex-dividend date was Wednesday, April 17th. Colgate-Palmolive’s dividend payout ratio is 57.91%.
In other news, VP Justin Skala sold 92,643 shares of the company’s stock in a transaction on Tuesday, May 7th. The shares were sold at an average price of $70.78, for a total value of $6,557,271.54. Following the sale, the vice president now directly owns 163,653 shares of the company’s stock, valued at approximately $11,583,359.34. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CEO Ian M. Cook sold 16,000 shares of the company’s stock in a transaction on Friday, March 15th. The shares were sold at an average price of $66.72, for a total transaction of $1,067,520.00. Following the completion of the sale, the chief executive officer now directly owns 1,146,793 shares in the company, valued at $76,514,028.96. The disclosure for this sale can be found here. Insiders sold a total of 335,211 shares of company stock worth $23,724,495 over the last ninety days. Insiders own 1.14% of the company’s stock.
COPYRIGHT VIOLATION WARNING: This story was originally reported by Ticker Report and is owned by of Ticker Report. If you are viewing this story on another site, it was illegally copied and republished in violation of U.S. and international copyright & trademark legislation. The correct version of this story can be viewed at https://www.tickerreport.com/banking-finance/4352982/fiduciary-group-llc-acquires-378-shares-of-colgate-palmolive-cl.html.
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. The company operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. It offers oral care products, including toothpastes, toothbrushes, and mouthwashes, as well as pharmaceutical products for dentists and other oral health professionals; and personal care products, such as liquid hand soaps, bar soaps, shower gels, deodorants and antiperspirants, skin care products, and shampoos and conditioners.
Featured Article: Different Types of Derivatives
Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CL).
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.